Advanced pretreatment clinical stage, low baseline CD4 T cell count, and diagnosis of tuberculosis (TB) after ART initiation had a higher risk of non-responsiveness and lower response rate to ART (Table 5). The gene discussed is CD4; the disease is tuberculosis.